CRIS Current Research Information System

LANZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.926
EU - Europa 1.292
AS - Asia 1.099
AF - Africa 57
SA - Sud America 5
OC - Oceania 4
Totale 4.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.909
IT - Italia 495
SG - Singapore 492
CN - Cina 327
GB - Regno Unito 195
VN - Vietnam 160
DE - Germania 149
SE - Svezia 119
IE - Irlanda 70
IN - India 50
UA - Ucraina 41
FR - Francia 38
CH - Svizzera 36
BG - Bulgaria 33
RU - Federazione Russa 30
FI - Finlandia 25
ID - Indonesia 20
CA - Canada 17
TG - Togo 17
CI - Costa d'Avorio 16
EE - Estonia 15
ZA - Sudafrica 15
JO - Giordania 14
NL - Olanda 13
HK - Hong Kong 9
TR - Turchia 9
NG - Nigeria 8
JP - Giappone 6
BE - Belgio 5
ES - Italia 5
GR - Grecia 5
KR - Corea 4
PL - Polonia 4
AT - Austria 3
AU - Australia 3
MY - Malesia 3
CL - Cile 2
DK - Danimarca 2
HR - Croazia 2
IS - Islanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BR - Brasile 1
EG - Egitto 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
Totale 4.383
Salva come PNG Salva come JPEG
Città #
Singapore 400
Boardman 271
Santa Clara 241
Fairfield 170
Southend 166
Ashburn 119
Chandler 105
Woodbridge 77
Houston 71
Dublin 70
Wilmington 67
Ann Arbor 61
Seattle 60
Bologna 59
Cambridge 51
Milan 47
Princeton 46
Frankfurt am Main 40
Dong Ket 39
Los Angeles 34
Sofia 33
Bern 28
Florence 26
New York 25
Jacksonville 24
Padova 21
Turin 21
Jakarta 20
Helsinki 19
Beijing 17
Lomé 17
Westminster 17
Abidjan 16
Nanjing 16
Guangzhou 15
Rome 15
Shanghai 15
Amman 14
Arezzo 11
Jinan 11
Naples 11
Berlin 10
Forlì 10
Fort Worth 10
Redmond 10
Saint Petersburg 10
Hong Kong 9
Zhengzhou 9
Abeokuta 8
Bremen 8
Changsha 8
Mülheim 8
Xi'an 8
Cesena 7
Hebei 7
Lugo 7
Prineville 7
Toronto 7
Belvedere Spinello 6
Catanzaro 6
Dongguan 6
Hangzhou 6
Jiaxing 6
Medford 6
Nanchang 6
Pisa 6
San Diego 6
Shenyang 6
Tianjin 6
Brussels 5
Chicago 5
Foshan 5
Istanbul 5
Izumo 5
Modena 5
Munich 5
Shijiazhuang 5
Springfield 5
Uppsala 5
Cologno al Serio 4
Falkenstein 4
Fuzhou 4
Lappeenranta 4
Mountain View 4
Newham 4
Parma 4
Qingdao 4
Ravenna 4
Suzhou 4
Wenzhou 4
Wuhan 4
Acerra 3
Athens 3
Cagliari 3
Des Moines 3
Falls Church 3
Freiburg im Breisgau 3
Genoa 3
Haikou 3
Kunming 3
Totale 2.920
Salva come PNG Salva come JPEG
Nome #
Stem Cells 239
A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. 193
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. 177
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 173
Cellule staminali. Embrionali, mesenchimali, emopoietiche, intestinali, cardiovascolari, muscolari, nervose e placentari 171
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. 142
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study 137
Umbilical cord blood CD34(+)cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functions. 126
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study 123
European Data on Stem Cell Mobilization with Plerixafor in Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Multiple Myeloma Patients. A Subgroup Analysis of the European Consortium of Stem Cell Mobilization. 111
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 107
null 97
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF. 87
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo. 82
null 81
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. 80
null 77
null 76
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 73
Vinciamo la vita. Oltre la cura il benessere. Un percorso di lungo periodo nell'alleanza medico paziente-famiglia. 67
Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a 59
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia 53
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients 50
Ibrutinib: from bench side to clinical implications 34
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 33
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 33
CD22 expression in b-cell acute lymphoblastic leukemia: Biological significance and implications for inotuzumab therapy in adults 30
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 30
Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study 29
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 28
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 26
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin 26
Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria 26
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients 26
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model 25
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 24
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 24
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT 23
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 22
Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study 22
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders 21
Novel insights and therapeutic approaches in secondary AML 21
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 21
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 20
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 20
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study 20
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 19
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 19
Cellule staminali circolanti in pazienti con infarto miocardico 18
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation 18
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study 18
Benessere Condiviso 17
Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment 17
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 17
A report from the SIdEM: Italy 17
The Circular Life of Human CD38: From Basic Science to Clinics and Back 17
CD116 (GM-CSF-R) 17
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 17
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders 16
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 16
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 16
XXXI National Conference of the Italian Society of Cytometry (GIC) October 8–11, 2013, Lucca, Italy 16
INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia 15
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have a common risk factors ? 15
Cytogenetic aspects of B- cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens 15
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 15
Citometria a flusso: applicazioni in ematologia 15
Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose 15
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 15
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 15
Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation 14
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 14
Development of adaptive immune effector therapies in solid tumors 14
Eterogeneita' immunofenotipica di cellule staminali mesenchimali dopo espansione ex vivo 14
CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 14
Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders 14
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3 internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 14
Cellule staminali circolanti in pazienti con infarto miocardico 14
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 14
Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis 14
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 13
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 13
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? 13
Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases 13
Results of the 6-Year Follow- up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia 13
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012 13
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach 13
Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions 13
Circulating human B and plasma cells. Age associated changes in counts and deteiled charaterization of circulating normal CD138- and CD 138+ plasma cells. 12
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia 12
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 12
Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT) 12
5 Anni di Ematologia a Ravenna e in Romagna 12
Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukaemia 11
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation 11
An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy 11
Adverse haematological effects of ticlopidine. A report of four cases 11
CD123 (Interleukin 3 receptor a chain) 11
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 10
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia 10
Totale 3.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020409 0 0 0 0 0 62 75 82 87 43 25 35
2020/2021365 55 23 9 13 3 11 1 33 43 15 23 136
2021/2022500 79 3 31 29 40 30 18 35 14 50 99 72
2022/2023932 50 69 35 61 34 37 12 149 165 132 92 96
2023/2024650 35 61 66 58 75 93 36 50 34 64 38 40
2024/20251.585 91 272 318 208 591 105 0 0 0 0 0 0
Totale 4.788